✦ LIBER ✦

Shorter hep C treatment duration approved in Europe

Book ID: 120843362
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816450-00042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination drugs: the future of hep B &

Combination drugs: the future of hep B & C treatment in Europe

✍ Okuda, Kotaro; Ishihara, Sho; Fujita, Yasuko; Yamamoto, Noriko; Kishimoto, Mitsu 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 124 KB

Triple therapy top treatment in hep C no

Triple therapy top treatment in hep C nonresponders

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Breast cancer in 2013: Genomics, drug ap

Breast cancer in 2013: Genomics, drug approval, and optimal treatment duration

✍ Lee, Adrian V.; Davidson, Nancy E. 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 612 KB

Novel all-oral hep C treatments deliver

Novel all-oral hep C treatments deliver in US

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

Promoting shorter duration of ventilator

Promoting shorter duration of ventilator treatment decreases the number of painful procedures in preterm infants

✍ A Axelin; U Ojajärvi; J Viitanen; L Lehtonen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Individualised vs standard treatment dur

Individualised vs standard treatment duration in hepatitis C

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB